Wecome Pharmaceutical Co Ltd (300878) — Free Cash Flow Generation Index
Wecome Pharmaceutical Co Ltd (300878) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of CN¥50.50 Million represents 1% of operating cash flow (CN¥50.89 Million). Read debt load of Wecome Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wecome Pharmaceutical Co Ltd Free Cash Flow Generation Index (2013–2023)
Historical FCF Generation Index trend for Wecome Pharmaceutical Co Ltd across 10 annual periods. Explore Wecome Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Wecome Pharmaceutical Co Ltd (2013–2023)
Year-by-year Free Cash Flow Generation Index for Wecome Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Wecome Pharmaceutical Co Ltd (300878) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -1.39x | CN¥-81.00 Million | CN¥58.29 Million | CN¥139.29 Million | ▼ -99.9% |
| 2022 | -0.70x | CN¥-101.88 Million | CN¥146.57 Million | CN¥248.44 Million | ▲ +72.8% |
| 2020 | -2.56x | CN¥-109.53 Million | CN¥42.81 Million | CN¥152.34 Million | ▼ -12928.6% |
| 2019 | -0.02x | CN¥-2.21 Million | CN¥112.76 Million | CN¥114.98 Million | ▲ +96.9% |
| 2018 | -0.64x | CN¥-67.16 Million | CN¥105.57 Million | CN¥172.73 Million | ▼ -41.5% |
| 2017 | -0.45x | CN¥-13.04 Million | CN¥29.00 Million | CN¥42.04 Million | ▼ -186.3% |
| 2016 | 0.52x | CN¥52.19 Million | CN¥100.15 Million | CN¥47.97 Million | ▲ +274.5% |
| 2015 | -0.30x | CN¥-8.85 Million | CN¥29.63 Million | CN¥38.48 Million | ▼ -357.7% |
| 2014 | 0.12x | CN¥5.33 Million | CN¥46.01 Million | CN¥40.68 Million | ▼ -79.2% |
| 2013 | 0.56x | CN¥14.51 Million | CN¥25.98 Million | CN¥11.48 Million | — |